Glybera gene therapy in approval process in Europe
Europe is on the process of approving a gene therapy for the first time, in what would be a landmark moment for the field.
Gene therapies alter a patient’s DNA to treat inherited diseases passed from parent to child.
The European Medicines Agency has recommended a therapy for a rare genetic disease which leaves people unable to properly digest fats.
The European Commission will now make the final decision.
The idea of gene therapy is simple: if there is a problem with part of a patient’s genetic code then replace that part of the code.
The reality has not been so easy. In one gene therapy trial a US teenager, Jesse Gelsinger, died, and other patients have developed leukaemia.
There are no gene therapies available outside of a research lab in Europe or the US.
The European Medicines Agency’s Committee for Medicinal Products for Human Use has considered the use of Glybera to treat lipoprotein lipase deficiency.
One in a million people have the deficiency. They have damaged copies of a gene which is essential for breaking down fat.
It leads to fat building up in the blood, abdominal pain and life-threatening pancreatitis (inflammation of the pancreas).
The only way to manage the condition is by having a very low-fat diet.
The therapy uses a virus to infect muscle cells with a working copy of the gene.
It was recommended for patients with severe pancreatitis, who cannot control the disease through diet.
The manufacturer, UniQure, said the decision was a “major breakthrough” for patients and medicine as a whole.
UniQure chief executive officer Jorn Aldag said: “Patients with lipoprotein lipase deficiency are afraid of eating a normal meal because it can lead to acute and extremely painful inflammation of the pancreas, often resulting in a visit to intensive care.
“Now, for the first time, a treatment exists for these patients that not only reduces this risk of getting severely sick, but also has a multi-year beneficial effect after just a single injection.
“Restoring the body’s natural ability to break down fat particles in the blood, in order to prevent pancreatitis and excruciating abdominal pain suffered by patients, is what gene therapy is all about: curing disease at the genetic level.”
Dr. Tomas Salmonson, from the agency’s Committee, said the use of Glybera should be restricted to patients “with greatest need”.
Related search articles:
- Powered by Article Dashboard spirituality magazine
- Powered by Article Dashboard total recreation
- Powered by Article Dashboard what is recreation therapy
- Powered by Article Dashboard recreation therapy centers in tn
- gene therapy skin whitening
- gene therapy for skin whitening in india
- kathia maria davis
- 2013 emphysema best new treatments
- worlds largest manufacture for phones
- why did burger king stop selling cini minis texas
- Stem cells for regenerating single sided deafness
- what parts of the world are effected by natural phenomena
- Predictions on Jodi Aries trial
- predictions on the jodi arias trial
- what is glybera
- Psychic perdictions of jodi arias trial
- PSYCHIC PREDICTION ON JODI ARIAS TRIAL
- university of michigan ann arbor and morgellon disease
- stomack virus 2013
- single sided deafness and stem cell research
- popping pimples meningitis
- 2013 yugioh forbes list
- 23 weeks neg hiv but symptoms
- belle wave stem -cellogist
- benefits of oil pulling therapy impotency
- breakthrough for HCV may 2013
- dr Joshua L Hood
- europe Aurora Forecast
- glybera gene therapy
- is Xi Mingze in america studying
- jodi arias trial psychic predictions
- lin jun chinese being murdered
- milkedon shoes
- oil pulling false claims?\
- PARIS JACCKSON 21013 PICTURES
- www xnxx arch/children-stabbed-december-2012/page/5/
Short URL: http://www.bellenews.com/?p=21791